Management of Spotting After 5 Years with Mirena IUD

Critical First Steps

The Centers for Disease Control and Prevention recommends ruling out IUD displacement by performing a speculum examination to check for the presence of IUD strings in patients with a Mirena IUD at the end of its 5-year lifespan 1, 2, 3
The American College of Obstetricians and Gynecologists suggests excluding pregnancy with a urine or serum pregnancy test, as ectopic pregnancy risk exists with IUD failure, in patients presenting with new-onset bleeding after 5 years of Mirena use 2, 4
The Centers for Disease Control and Prevention advises screening for sexually transmitted infections, such as gonorrhea and chlamydia, particularly if the patient has risk factors, as STDs can present with abnormal bleeding in Mirena IUD users 1, 2, 3
The American College of Obstetricians and Gynecologists recommends evaluating for new pathologic uterine conditions, including polyps, fibroids, or endometrial pathology, especially since new-onset bleeding after years of stable use suggests underlying gynecological problems in patients with a Mirena IUD at the end of its 5-year lifespan 1, 2, 3

The Infectious Diseases Society of America notes that Actinomyces infections, though uncommon, occur most frequently when IUDs are left in place past the recommended 5-year removal time, and considers the timing critical in patients presenting with new-onset bleeding after 5 years of Mirena use 5
The American College of Obstetricians and Gynecologists states that new-onset bleeding after 5 years of use warrants investigation, as most Mirena users have achieved amenorrhea or oligomenorrhea by this time, and breakthrough bleeding represents a change from baseline 1, 2, 6

The American College of Obstetricians and Gynecologists suggests considering NSAIDs for 5-7 days during bleeding episodes as first-line symptomatic treatment in patients with a Mirena IUD at the end of its 5-year lifespan and no underlying pathology found 3, 4
The American College of Obstetricians and Gynecologists recommends counseling about IUD replacement, since the device is at its 5-year endpoint, and discussing removal and replacement with a new Mirena versus alternative contraceptive methods in patients with a Mirena IUD at the end of its 5-year lifespan 1, 7

The Centers for Disease Control and Prevention advises against assuming spotting is "normal" at 5 years, as bleeding at this timepoint suggests either device expiration or new pathology in patients with a Mirena IUD at the end of its 5-year lifespan 1, 2, 6
The Infectious Diseases Society of America warns against delaying evaluation, as the combination of 5-year duration and new bleeding requires prompt assessment in patients with a Mirena IUD at the end of its 5-year lifespan 1, 5
The American Heart Association recommends assessing cardiovascular risk before prescribing NSAIDs or hormonal treatments, as these carry thrombotic risks in certain populations, in patients with a Mirena IUD at the end of its 5-year lifespan 4

The American College of Obstetricians and Gynecologists recommends explaining that the Mirena is FDA-approved for 5 years, and the patient has reached the replacement timepoint, in patients with a Mirena IUD at the end of its 5-year lifespan 1, 7
The American College of Obstetricians and Gynecologists suggests discussing that while bleeding irregularities can occur with hormonal IUDs, new-onset bleeding after years of stable use requires evaluation, in patients with a Mirena IUD at the end of its 5-year lifespan 1, 6